Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Hair cortisol can indicate long-term stress levels, but hair growth rate differences may affect accuracy.

Polymeric nanoparticles effectively control corticosteroid release and penetration for skin applications.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Hair cortisol content can indicate cortisol exposure and varies with age, puberty, and BMI in youth.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Misusing topical corticosteroids can cause skin darkening and other side effects.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

The combination of calcipotriene and betamethasone is more effective and has fewer side effects for treating psoriasis.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Progesterone protects brain cells by converting to allopregnanolone and involving GABAA receptors.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Ketoconazole improved symptoms of ACTH-independent Cushing syndrome despite inconclusive initial scans.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.